Infrared spectroscopy and imaging technology can provide new diagnostic capabilities for cancer research applications and to physicians directly involved in patient treatment. A methodology that permits the phenotypical description of cells and tissues is introduced, as well as a variety of new evaluation techniques that allow researchers and physicians to evaluate the infrared data at different levels of sophistication. The detection of cell alterations in the case of Chronic Lymphocytic Leukemia (CLL) demonstrates the capability of infrared spectroscopy to identify and stage this type of cancer, providing new prospects for diagnosis and treatment. The pathological study of oral tissue affected by Squamous Cell Carcinoma (SCC) illustrates the potential of Infrared Spectroscopy and Imaging for tissue diagnosis and cancer staging based in altered cell biochemistry, without using stains or any other marker technology. An example of combined fluid, cell and tissue analysis of thyroid cancers based on infrared technology is introduced to demonstrate the possibility of earlier detection of gland abnormalities and biochemical alterations in cell extracts using fine needle aspirates. Simple statistical techniques such as bivariate histogram analysis can distinguish between normal and altered cells and tissues when applied to infrared spectra and images. More complex mathematical techniques such as Principal Component Analysis (PCA) or Artificial Neural Networks (ANN) provide additional evaluation capabilities that can relate spectra of an unknown sample to an infrared reference database of known cell states. It is documented how this new infrared technology could enhance the diagnoses, treatment decisions and prognoses of patients in the field of cancer medicine.
Introduction
In much the same way as Magnetic Resonance Imaging (MRI) and Spectroscopy (MRS) provided medicine with entirely new capabilities for diagnosis and treatment, another spectroscopic method is poised to enter the biomedical arena -Fourier Transform Infrared Imaging (FT-IRI) and Infrared Spectroscopy (FT-IRS). Whereas MRI and MRS allow physicians to see macroscopic tissue structures in-vivo inside a patient, FT-IRI and FT-IRS can support complex diagnoses of altered biochemistry at the cellular level in vitro and in vivo (1) (2) (3) (4) (5) (6) (7) (8) (9) . Whether this new methodology is applied in cell line research and pathology or whether fiber optics technology supports in vivo diagnosis during surgery, the complex biochemical fingerprint of cells and tissues can be followed and monitored under many different conditions. Today's rapidly expanding and more powerful clinical diagnoses of many diseases have created a necessity for methods that can detect cellular fingerprints more precisely than ever before. Infrared spectroscopy has come a long way from its discovery more than a century ago to current applications in almost any discipline in science. As in the case of other spec-Christian P. Schultz, Ph.D.
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Billerica, MA 01821, USA troscopic and imaging techniques, the introduction of Fourier Transform technology has transformed infrared spectroscopy from a scouting technique in chemistry, to a high-tech precision tool for substance analysis ranging from interstellar sciences to medicine. Current Fourier transform infrared (FT-IR) technology is very mature and can be applied either to monitoring toxic gases or to identifying bacteria at the strain level and has even been very successfully utilized to diagnose different types of cancers.
The principle of infrared spectroscopy is simple and based on the fact that almost all molecules absorb infrared radiation. This effect occurs at specific frequencies depending on the chemical structure of any given molecule, which then results in a fingerprint like pattern of absorbed infrared radiation that identifies this particular substance. Although similar chemicals show similar fingerprint like patterns (called spectra), not one single substance has an identical spectroscopic pattern compared to another substance. This simple rule provides all the potential of infrared spectroscopy as a unique tool for substance identification and classification based on reference materials. Since infrared radiation is only absorbed if the natural vibration of a molecular bond in a molecule can be stimulated to a higher excited vibrational state, every single bond therefore has the potential to contribute to an infrared spectrum. This law in molecular physics leads to the simple rule that a molecule with N atoms will provide a spectroscopic pattern consisting of 3N-6 vibrational modes. Many biomolecules in cells and tissues contain far more than 100 atoms thereby each generating complex infrared spectra formed by many different vibrations. Cells then contain an almost infinite number of different molecules, which provide infrared spectra with virtually an infinite number of vibrations. It is immediately obvious that different cells, or even different development states of a cell, would automatically create a different infrared fingerprint, identifying either the type or the state of the cells based on their different biochemistry.
The spectral range most familiar to many scientists and physicians is in the visible and the UV where nanometers are used to scale the frequencies in this relatively narrow range of radiation. In contrast, infrared spectroscopy covers a much broader range of frequencies (780 -2,000,000 nm), which includes the Near-, the Mid-and the Far-infrared region. The micrometer scale is therefore mainly used among infrared spectroscopists to describe this spectral frequency range. For practical reasons the x-axis of infrared spectra is normally expressed in Wavenumbers (cm -1 ) -the inverse of the wavelength of the infrared radiation (ν = 1 / λ). This unusual historical measure for scaling not only provides a unit that is directly proportional to the energy of the photons, it also comes with the benefit of creating symmetric shapes for all infrared absorption bands ideal for fitting and other mathematical calculations. Basic vibration modes of many molecules can be found in the spectral range 2.5 -25 µm, which translates into 4000 -400 cm -1 on the Wavenumber scale defining the main spectral range in the Mid-infrared. Many types of molecular vibrations characterizing many different molecules can be found in this infrared region, however, they can be simply grouped into stretching vibrations, deformation vibrations and torsion or skeleton vibrations. The molecular motions involved consist of bond length and bond angle changes, which move individual atoms or groups of atoms slightly out of position. It is evident that the complex motions of atoms in molecules involve a multitude of different energies, especially if the atoms are of different weights and connected by different bond types such as single, double or triple bonds. Infrared spectroscopists therefore developed the so-called group frequency concept that allows the description and identification of functional groups in molecules such as ester and amide groups. As a direct consequence, bands in certain spectral regions can define the substance classes present in a sample.
Infrared technology experienced a renaissance of application and development after the introduction of interferometry and digital data acquisition and processing. Both implementations contributed to today's wavenumber accuracy (0.01 cm -1 ), the very high reproducibility, the low sampling noise (10,000:1 Signal-to-Noise) and the possibility to create database reference libraries of many substance classes. In addition, new sampling techniques have been introduced, currently enabling measurement of samples in any solvent, as well as the measurement of watery cell suspensions, dried films, etc. Infrared spectra of cells can be utilized to identify and classify cell types e.g. as in the case of infrared techniques that permit the identification of bacteria to the strain level. Generally, infrared spectroscopy and imaging can be applied either to macroscopic or microscopic assemblies of cells and tissues, enabling samples to range from a few microns to centimeters (or virtually any larger size). Individual cells can be harvested and cell suspensions can be dried as films on IR-transparent window materials. Cells can also be measured in vivo if they adhere as biofilms in solution on the surface of material that can be utilized for infrared spectroscopy (10-12). Infrared microscopy applied to cells and tissues extends the capabilities of this methodology to single cell measurements. Tissue structure and organization as well as cell morphology can be investigated and supplemented with the biochemical information contained in the infrared spectra (13).
The potential of infrared spectroscopy and imaging will be demonstrated on five different aspects of cell and tissue analyses related to cancerous alterations. The chronic lymphocytic leukemia study will describe the diagnostic power of infrared technology for the determination of cancerous alterations in blood cells. The oral cancer study on excised micro tissues of 1-2 mm 2 will introduce the various concepts of different analyses of infrared data and their merits for clinical diagnoses. The thyroid study will illustrate the possibilities of infrared technology in early diagnosis of gland abnormalities even in cases where traditional technologies can fail. Finally, the study on cancer cell systems will present the power of infrared technology for cell and drug-treatment research in the clinical environment, illuminating the process of apoptosis and necrosis due to early cell alterations.
Materials and Methods
Cell and tissue samples were obtained from a variety of sources over the past 8 years, as documented below. Lymphocytes were isolated from volunteers and patients with Chronic Lymphocytic Leukemia in collaboration with Dr. J. B. Johnston at the Health Sciences Center (Winnipeg, MB Canada). Thyroid tissue samples were obtained from surgical specimens after partial or complete removal of the thyroid gland in collaboration with Dr. K. T. Riese at the St. Boniface General Hospital (Winnipeg, MB Canada). Fluids and cells of the thyroid gland were obtained by aspiration collected for standard diagnoses in collaboration with Dr. E. A. Salamon at the Winnipeg Clinic (Winnipeg, MB Canada). Tissue specimens with potential invasion of squamous cell carcinoma were obtained from patients in collaboration with Dr. P. Kerr at the Health Sciences Center (Winnipeg, MB Canada). Cancer cell lines and drug treatment procedures to study necrosis and apoptosis were carried out at the Manitoba Institute of Cell Biology in collaboration with Dr. M. R. Mowat. The tissue analyses were performed on frozen thin sections of 6-8 micron thickness cut with a cryo-microtome at -22º C. Tissue samples were cut into consecutive slices and placed on glass slides for staining and on IR-transparent windows (BaF 2 and CaF 2 ) for infrared analysis. The rapid, almost instantaneous, drying process occurred under a nitrogen gas stream and the final slides were stored under nitrogen-purged conditions to prevent tissue oxidation. Most tissue slides were stained following standard histochemical procedures such as hematoxylin and eosin (H&E) staining, while some tissue samples and most cell samples were exposed to Gimsey quick staining. Lymphocytes were separated from all other blood cells, transferred into saline and then dried as monolayer films on IR-transparent window material (BaF 2 and ZnSe). To clarify a frequently asked question about modern infrared sampling techniques, none of the cell and tissue samples mentioned above were ever measured in the form of traditional KBr pellets -an old technique which is still believed to be commonly in use in infrared spectroscopy.
A variety of instruments, predominantly of Bruker Optics origin, were employed for the infrared measurements. Most infrared microscopy was carried out on an IRscope II connected to a Fourier transform infrared spectrometer Equinox 55 (Bruker Optics Inc, Billerica, MA), equipped with a small element HgCdTe detector (MCT) cooled with liquid nitrogen. Infrared microscopic imaging was performed on a Hyperion configuration of the IRscope II connected to an IFS 66/s step-scanning Fourier transform infrared spectrometer (Bruker Optics Inc, Billerica, MA), equipped with a 64x64 elements square HgCdTe focal plane array detector (FPA). Infrared Mapping and Imaging were made through Cassegrain objectives with either 15x or 36x magnification. The smallest effective area for single cell measurements through a set of knife-edge apertures was 15x15 microns 2 . The single effective pixel size in case of the FPA detector was 4.2x4.2 microns 2 (15x objective) and 1.8x1.8 microns 2 (36x objective). Since the applied wavelength of the infrared radiation ranged from 2.5-25 microns and the achievable spatial resolution is defined by the diffraction limit of the radiation (half the wavelength 1.25-12.5 microns), the infrared imaging experiments performed were very close to or within the absolute spatial resolution limit achievable with infrared radiation. The spectral data resolution with which the spectra for microscopy were collected was set to 8 cm -1 . The cell fragment, biofluid and cell line studies were mostly performed on the IFS 28/B (MICOR-ID) Fourier transform infrared spectrometer (Bruker Optics Inc, Billerica, MA), equipped with a dedicated sampling system designed for bacterial identification. Some of the cell studies were carried out on a FTS-40A Fourier transform infrared spectrometer (Bio-Rad, Cambridge, MA). The spectral data resolution for the biofluid and cell studies was also set to 8 cm -1 .
The infrared spectral information was analyzed by applying single band analysis and statistical routines available within the program package for FT-IR spectrometers -OPUS TM (Bruker Optics Inc, Billerica, MA). The bivariate statistical analyses were performed based on software modules available within the statistics package Statistica TM (Statsoft, Tulsa, OK). The Artificial Neural Network (ANN) analysis with the infrared imaging data was carried out with the program package NeuroDeveloper TM (Synthon KG, Gusterath, Germany) in collaboration with Dr. J. Schmitt and Dr. T. Udelhoven. Details of the evaluation procedures for spectral analysis and image reconstruction based on infrared data evaluation have been published previously (12) and are generally described in many journals (1-5, 10, 14-15).
Results and Discussion

Infrared Blood Cell Diagnosis in Chronic Lymphocytic Leukemia
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of non-proliferating mature-looking lymphocytes in the peripheral blood. With the progression of the disease, severe cell and tissue alterations can be diagnosed such as lymphadenopathy, spleno-megaly and replacement of the marrow by leukemic cells. The lymphocytes appear to be frozen within the normal path of differentiation and show accumulation rather than proliferation, which is caused by a reduction in the rate of spontaneous apoptosis. Many cells show genetic alterations and are often of CD5 + B cell type. Although all affected cells are somewhat different compared to normal cells, the population of these tumor cells is very heterogeneous in morphology, chromosomal contents and many other factors, presenting a real diagnostic challenge to physicians. This is the access point for infrared spectroscopy as a clinical method. Since infrared spectra provide a cellular fingerprint of all biomolecules contained within a cell, complex alterations in cellular phenotype are therefore the ideal setting for a possible infrared diagnosis.
The three sections in Figure 1 show the simple comparison of infrared survey spectra of normal lymphocytes and CLL cells, as well as a classification approach of normal and abnormal cells with a dendrogram of spectral similarity to the lower right and cluster mean spectra to the lower left. The two infrared survey spectra are very similar in appearance and illustrate the general spectral features of cells.
Since they each show all the biomolecules of a cell and the general makeup of cells include molecules such as proteins, lipids, metabolites, DNA/RNA, and carbohydrates, the similarity of these fingerprint-like spectra is not surprising. Small visible alterations in infrared survey spectra of cells are normally indicative of major biochemical changes within cells. For this statement to be true, high quality conditions for the infrared measurements (low spectral noise and no preparation artifacts) as well as reasonable statistics to cover variations between different cell isolations, are necessary. The cluster analysis (a non-supervised pattern recognition method) of hundreds of normal and CLL cell isolates demonstrates that a small spectral region can be utilized to distinguish the two different cell types with infrared spectroscopy. This initial diagnosis is normally established based simply on the number of lymphocytes in the peripheral blood and not on cellular alterations. Infrared spectroscopy can convincingly show that it can detect (beyond visual inspection of slides of blood smears) phenotypic alterations in CLL cells, which could potentially be used for staging of CLL and may provide more information on the expression of this disease than any other method. illustrate a stable situation (patient 1), a rapidly progressing disease state (patient 2) and an unstable situation with partial remission (patient 3). Visually normal lymphocytes can be staged without further complex biochemical and immunological analysis and this new diagnostic tool may even predict the outcome of drug-treatment in a much shorter time frame. These promising results may also provide the foundation for a future diagnostic tool of blood cancers in hematology (for more detail see also 7, 16-20).
Tissue Diagnosis in Oral Squamous Cell Carcinoma
In a similar manner to the previous Leukemia study, infrared spectroscopy can also be utilized to detect cell alterations in squamous oral mucosa. The main difference in the two studies is the detection of cancer in isolated blood cells versus the detection in tissues in the case of squamous cell carcinoma (SCC). Alterations in tissue structure and organization normally provide clues to a pathologist that could help identify the form and stage of abnormalities. However, as in the case of CLL, cell alterations under abnormal conditions may occur before structural alteration can be seen in tissues. It is important to be able to distinguish benign conditions such as epithelial hyperplasia from malignant cancer stages. In this case, keratin proteins are considered markers to distinguish normal from cancerous epithelial tissues. There are seven different classes of keratins present in cells indicating the different stages of cell differentiation. Monoclonal antibodies have successfully been applied to achieve the goal of a sophisticated diagnosis of epithelial growth abnormalities. However, the interplay between keratins and the complex composition of epithelial cells turns such a diagnosis of epithelial abnormalities into a difficult and expensive task. Infrared spectroscopy and imaging can potentially provide information about cell alterations that may be easier and earlier to detect and classify. The following results illustrate the technique of infrared imaging and a potential diagnostic tool simply utilizing spectral properties transformed into biochemical tissue maps.
The graphs in Figure 3 illustrate typical infrared survey spectra of tissue thin sections of oral mucosa. The one cell layer thick section was H&E stained after the infrared measurements of defined tissue areas had been performed. Every layer of cells in this rapidly growing epithelium shows slightly different properties in the infrared spectra. Surface glycosylation for example can be seen in the spectral range from 1000-1200 cm -1 , which shows a distinct pattern in the surface layer spectrum (SL) compared to the spectra of the intermediate layer (IL) or the basal layer (BL). Again the main features in the infrared spectra look very much the same but those features that characterize a distinctive cell type clearly appear in the infrared spectra. A more detailed view of this situation is demonstrated in Figure 4 . The larger rectangular area marked in Figure 3 was imaged with the infrared microscope and a series of hundreds of spectra was evaluated to create biochemical maps of DNA and keratin. The spectral region of interest for the data evaluation is displayed in Figure 4G . Simple integration of the marker bands of DNA (at 968 cm -1 ) and of keratin (at 1305 cm -1 ) allows the generation of two dimensional intensity maps of DNA and keratin, which are quantitative in nature and reflect the content of material relative to the thickness of the sample. In normal tissue, epithelial keratin is only produced into the epithelium starting with the basal layer (BL → IL → SL), whereas the submucosa (SM) remains free of those types of keratins (see Figure 4E ). The opposite profile can be detected for DNA. Since the basal layer cells are continuously producing the epithelium, DNA is actively read and copied and therefore clearly visible in the chemical maps (see Figure 4C ). In contrast, the DNA/RNA is reduced and tight- ly packed in the cells of the intermediate layers and therefore also disappears from the infrared spectra. The ratio of DNA per cell becomes smaller and smaller the further the cells are away from the basal layer. This is different in squamous cell carcinoma tissues. The chemical maps suggest a generally higher cell activity in tissues formed within the intermediate layers (see Figure 4D ) and show keratin enrichment totally out of proportion in randomly distributed spherical bodies (keratin pearls) in the case of well-differentiated SCC. The abnormal epithelial growth pattern (growing into a sphere) is optically a clear indicator for well-differentiated SCC; however, the cells with higher DNA content suggest that some of these cells and tissue areas have a much poorer prognosis.
Biochemical maps of tissues can be generated in many different ways and carry an enormous amount of information on the cells and tissues. Figure 5a demonstrates that these biochemical images can describe many different properties of a sample either by evaluating single bands of infrared spectra or by performing Principal Component Analysis (PCA) on the entire set of infrared spectra in the image. In many cases, it seems to be sufficient for the initial diagnosis, to compare multiple infrared bands that indicate different biochemical properties (9). Plotting those properties in the form of bivariate histograms will provide physicians with a familiar format in which the information can be evaluated and assessed (9, 14) . However, since infrared spectra of cells and tissues are highly complex due to the sheer number of contributing biomolecules, it seems that more complex evaluation techniques are required to extract more of the information contained in infrared tissue images. PCA and artificial neural networks (ANN) not only provide this capability, they also allow a significant data reduction, from the relatively large infrared raw images to only a few factor or cluster images. The number of differentiating factors is normally relatively small (<20) and provides information about contributing properties present in the sample. These socalled loading factors can be utilized to establish a tissue classification system that can distinguish normal from abnormal structures, as well as between different tissue development stages. However, loading factors extracted from a PCA are presented in a gradual intensity distribution basically displaying the similarity of tissue areas. If a new tissue structure is presented to an identification system based on PCA, the response is simply that there is only low similarity to elements in the existing tissue database. This is different with the ANN approach, which is therefore more applicable in clinical environments. A network trained to recognize certain tissue structures identifies tissue areas as entire clusters of tissue with similar properties (see Figure  5b ). If a new tissue structure is brought into the analysis, the ANN response is that this new tissue structure cannot be recognized and is therefore classified as unknown. At a later stage after the identification of the new tissue structure, this information can be added to the ANN network increasing its range of identification.
Combined Cell, Fluid and Tissue Diagnosis in Thyroid Cancer
Glandular cancers such as thyroid cancer present a different diagnostic challenge to those of the blood and epithelial cancers presented above. Samples may not easily be obtained by simply collecting blood samples or surface biopsies from epithelia. Early diagnosis is as important as the application of a successful diagnostic procedure that allows the retrieval and identification of abnormal cells from the tissue affected. Large areas of the tissue may be affected, but the cancerous lesions needed for a positive diagnosis could be contained in only a small area. Since in many cases it is necessary to utilize simple palpation in combination with needle aspiration, it is often difficult to obtain diagnostically relevant cells. In cases where cells could be harvested through needle aspiration, tissue structure is mostly destroyed and the only relevant tool for a possible diagnosis remains cytology, often solely based on the morphology of the nucleus. Infrared spectroscopy can add new capabilities at multiple levels to this critical diagnostic procedure using the spectroscopic fingerprint of cells, tissues and even the fluid aspirated (21).
The stained images in Figure 6 show intact thyroid tissue from surgically excised gland material, cell clusters from fine needle aspirates and one image of a giant cancer cell, which provided grounds for a clear diagnosis. The cell clusters, however, do not display any features that would possibly allow an association with the cellular structure of the excised tissue. The infrared microscopic measurements of these cell clusters and tissue fragments provided spectroscopic information that could be used to identify the cell type as normal or abnormal. The reference database for the iden-
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Technology in Cancer Research & Treatment, Volume 1, Number 2, April 2002 Figure 5b: Comparison of loading factor #0 of the PCA with the cluster results of an artificial neural network (ANN) approach. The PCA provides a similarity image of a property whereas the ANN analysis creates clusters of tissue structures recognized. If the ANN cannot identify the tissue, it will create an output of "unknown" tissue structure, which is ideal for staging of cancers.
tification was created based on datasets of entire tissue thin sections of different origin such as normal thyroid tissue, adenoma and carcinoma samples. Bivariate histograms of these datasets were created based on the evaluation of two parameters -the intensity of protein (at 1550 cm -1 ) and DNA (at 968 cm -1 ). Figure 7 shows how an unknown sample can be identified, based on simple referencing of the two parameters in a single measurement, relative to those of the databases. The sample illustrated is referenced against normal tissue, follicular adenoma, medullary and papillary carcinoma. The reference point of the unknown sample clearly shows that it is out of the range if compared to normal tissue. The infrared method also suggests that it may fit cell types present in the database of follicular adenoma. This relatively simple tool may provide new diagnostic capabilities to cytologists when challenged with this type of diagnosis. As an important addition, this method also provides results in cases where no cells could be obtained with needle aspiration (see reference 21). The concept is very simple and the identification is based on pattern recognition techniques applied to infrared spectra of biofilms prepared from the aspirates. In cases where cells were obtained and a diagnosis could be established, simple centrifugation allowed the removal of the cells and the remaining fluid to be utilized to build a reference database. If a sample with no cells were later obtained, it could be compared with the spectra from the fluid of the previously identified samples and the results used to predict the nature of the aspirate. This concept only works, because the entire tissue region of the gland affected expresses an altered biochemistry and this difference is reflected in the fluidic part of the aspirate (for more details see 21).
Programmed Cell Death and Necrosis in Cancer Cell Lines
Finally, infrared spectroscopy and imaging have been established in the field of cell research and applied to methods that investigate drug cell effects. Since cell death is a major event in a cell's life cycle and the biochemistry is normally dramatically altered, processes such as apoptosis and necrosis should certainly be detected by methods that are able to examine all the biochemicals in cells and tissues. Apoptosis is an organized event that causes a cell to die without creating an environment that would also affect the surrounding cells. A cascade of events eventually transforms the cellular components into smaller packets that the organism can discard. Necrosis is the event that occurs, when a cell does not have the time to either initiate apoptosis or finish it appropriately. This type of destruction exposes cell enzymes and other cellular components to the surrounding and can cause major damage to the nearby cells, which can also undergo necrosis due to this exposure. The following results will demonstrate that infrared spectroscopy has the capability to distinguish not only normal cells from apoptotic cells it also distinguishes necrotic cells from those cell types.
This work was initially introduced as a combined nuclear magnetic resonance (NMR) and infrared spectroscopy study in 1997 and 1998 at ISMRM (22-24). One study demonstrated that treating lymphocytes of patients with CLL with chlorambucil (CLB) and 2-chlorodeoxy-adenosine (CdA) can alter their metabolism and composition of cellular components such as the relative amount of DNA. The other two studies showed that both methodologies could detect the early onset of apoptosis and necrosis in model systems by treating HeLa cells with etoposide and ethacrynic acid, respectively. Figure 8 illustrates the detection of the many different infrared spectroscopic features caused by apoptosis and necrosis. For the first time infrared spectroscopy detected that the protein composition of cells shifts dramatically towards more alpha-helical proteins during apoptosis. In addition, since the formation of apoptotic bodies requires a larger surface coverage with membranes, it was not surprising that more lipid could also be detected in apoptotic cells (see Fig 8) . The cell response to necrosis is completely different. The cells seem to form protein aggregates instantaneously and smaller molecules such as cell metabolites are already visible during the initial stages of necrosis. Chemical or mechanical stress, or random membrane ruptures, could cause this uncontrolled cellular biochemistry, breaching the cell environment. Both processes are so different that they can be recognized very early on during apoptosis and necrosis. This study shows that infrared spectroscopy can contribute significantly to modern drug discovery, as well as to settings in clinical environments where the drug response of cells isolated from patients can be externally tested before the drug is actually applied. This could prevent the complex problem of resistance development in cancer cells due to the optimal and initial use of the most effective drug. This initial study is the basis on which recent publications using IR (see 25) and NMR (see 26) are built.
Conclusions
Infrared spectroscopy and imaging are undergoing a process that will enable transition of this technology into the medical environment, in a very similar manner to the transformation from research NMR into the biomedical MRI and MRS technology present in hospitals today. The fact that infrared technology offers new and unique concepts and advantages for the analysis of cells and tissues, and that complex mathematical methods can now manage the amount of information extracted from infrared spectra, will help with this transition. The research and diagnosis of complex processes such as apoptosis and necrosis will become easier due to the capabilities of the new technology to obtain fingerprints of such complex cell states. It also seems feasible that it can assist the pathologist with the redefinition of some of the intermediate cancer stages. Since infrared spectra of tissues can be utilized to train methods to recognize their biochemical fingerprint, infrared imaging and spectroscopy may be able to guide pathologists in cases where it is difficult to distinguish very similar cell states (for more information see references 27-29).
